HFpEF Explained — Living with HFpEF | NEJM

Why It Matters

HFpEF affects millions and now has proven therapies; patient‑centered monitoring and self‑advocacy can lower hospital admissions and extend healthy living.

Key Takeaways

• HFpEF causes stiff heart, not weak pumping function
• New therapies in past five years improve HFpEF outcomes
• Daily self‑monitoring of weight, blood pressure, and sodium essential
• Structured exercise and low‑salt diet lower hospitalization risk
• Patient advocacy and proactive communication boost treatment effectiveness

Summary

The NEJM video spotlights heart failure with preserved ejection fraction (HFpEF), a condition where the heart muscle contracts normally but fails to relax, leading to fluid buildup and breathlessness. The patient narrator shares a four‑year diagnostic odyssey, emphasizing that early recognition and modern therapies can dramatically alter the disease trajectory. Key insights include the distinction between stiff and weak hearts, the emergence of effective medications over the past five years, and the critical role of daily self‑monitoring—weight, blood pressure, and sodium intake—to preempt decompensation. Structured exercise, low‑salt diets, and vigilant symptom tracking are presented as foundational lifestyle interventions. Memorable quotes illustrate the experience: “My heart isn’t too weak to pump, it’s too stiff to pump,” and practical tips such as watching hidden sodium in bread and reporting a three‑pound weight gain within 24 hours as a fluid alert. The narrator also stresses writing five questions for each doctor visit to ensure active advocacy. For clinicians and health systems, the video underscores that HFpEF, once deemed untreatable, now has evidence‑based pharmacologic options and that empowering patients with monitoring tools can reduce costly hospitalizations while improving quality of life.

Original Description

In this final episode of a three-part Double Take miniseries on heart failure with preserved ejection fraction (HFpEF) from the New England Journal of Medicine, Lori Hogan and Janice Williams describe what living with HFpEF is like. This patient-focused video explains the condition and offers practical approaches to managing it as a chronic illness.

Funding for this Double Take is provided by the Doris Duke Foundation, committed to building a creative, equitable, and sustainable future.

#medicaleducation #clinicalmedicine #nejm

The New England Journal of Medicine is the world’s leading general medical journal. Continuously published for over 200 years, the Journal publishes peer-reviewed research along with interactive clinical content for physicians, educators, and the global medical community at NEJM.org.